Occasionally, we will have special announcements of current health issues that we feel everyone should know about, and we do our best to deliver as much information we can about them. In this case, it is the alarming rise in cases of Enterovirus nation-wide, and concerns both health officials and the Centers for Disease Control (CDC) have about this mysterious illness. Over the next few weeks we will be following this developing story and provide links to as much information on its spread, known symptoms, and what health and CDC officials recommend the public can do to guard against it.
On September 26, 2014, the CDC issued an Official Health Alert Network (HAN) Advisory, Acute Neurologic Illness with Focal Limb Weakness of Unknown Etiology in Children. The HAN’s purpose is to spread awareness of the neurologic syndrome and to help determine its geographic spread.
Currently, the CDC is investigating nine cases of the acute neurologic illness among pediatric patients, among the ages of 1-18 years.
According to the report, “Common features included acute focal limb weakness and specific findings on magnetic resonance imaging (MRI) of the spinal cord consisting of non-enhancing lesions largely restricted to the gray matter. In most cases, these lesions spanned more than one level of the spinal cord. Some also had acute cranial nerve dysfunction with correlating non-enhancing brainstem lesions on MRI. None of the children experienced altered mental status or seizures. None had any cortical, subcortical, basal ganglia, or thalamic lesions on MRI. Most children reported a febrile respiratory illness in the two weeks preceding development of neurologic symptoms. In most cases, cerebrospinal fluid (CSF) analyses demonstrated mild-moderate pleocytosis (increased cell count in the CSF) consistent with an inflammatory or infectious process. CSF testing to date has been negative for West Nile virus and enteroviruses, including poliovirus.”
The United States is currently experiencing a nationwide outbreak of EV-D68 associated with severe respiratory disease.
The CDC lists a number of recommendations and provides contact information to report suspected cases:
Patients ≤21 years of age with